Using liquid chromatography with tandem mass spectrometry, Kozak et al. found that TTR, in combination with beta-haemoglobin, apolipoprotein AI, transferrin and CA125, significantly improved the detection of early stage ovarian cancer [101]. This evidence concerns the gene TTR and ovarian carcinoma.